HIV shots for kids: could injections replace daily pills?
NCT ID NCT05660980
First seen May 09, 2026 · Last updated May 20, 2026 · Updated 3 times
Summary
This study is testing a long-acting injectable HIV medication (cabotegravir and rilpivirine) in children aged 2 to 12 who already have their HIV under control with daily pills. The goal is to see if switching to monthly or every-other-month shots is safe, tolerable, and works as well as the pills. About 90 children will participate, starting with oral tablets to check safety before moving to injections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CRS 31784, Chiang Mai University HIV Treatment CRS
RECRUITINGChiang Mai, 50202, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CRS 5071, Instituto de Puericultura e Pediatria Martagao Gesteira Clinical Research Site
RECRUITINGRio de Janeiro, 21941-590, Brazil
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
CRS 8052, Soweto IMPAACT
RECRUITINGJohannesburg, 1864, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Siriraj Hospital, Mahidol University NICHD CRS (Site #5115)
RECRUITINGBangkok, Bangkoknoi, 10700, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 12701, Gaborone CRS
RECRUITINGGaborone, Botswana
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 12702, Molepolole CRS
RECRUITINGGaborone, Botswana
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 30300 Umlazi CRS Site
RECRUITINGUmlazi, KwaZulu-Natal, 4066, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 5030, Emory University School of Medicine NICHD CRS
RECRUITINGAtlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 5073, SOM Federal University Minas Gerais Brazil NICHD CRS
RECRUITINGBelo Horizonte, 30130-100, Brazil
Contact Phone: •••-•••-••••
-
Site 5116, Chiangrai Prachanukroh Hospital NICHD CRS
RECRUITINGChiang Rai, 57000, Thailand
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 6501, St. Jude Children's Research Hospital CRS
RECRUITINGMemphis, Tennessee, 38105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Site 8051, Wits RHI Shandukani Research Centre CRS
RECRUITINGJohannesburg, 2001, South Africa
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.